Apath, LLC is a pharmaceutical discovery and development company with a focus on hepatitis C virus (HCV) and other human viral pathogens. The firm is engaged in the commercial application of virology and viral genetics to discover and develop a range of novel therapeutic products for the treatment of viral infections. Apathâs primary focus is on RNA viruses. RNA viruses account for the majority of viruses which are human pathogens. In addition to HCV, they include several medically important viruses â Influenza, Respiratory Syncytial Virus (RSV), and Hemorrhagic Fever Viruses. The firm successfully licensed their key hepatitis C virus patents to several diagnostic and pharmaceutical compan
